CEU Miami 2018 - Program

CEU Day 1 Topics - Calcium/Bone, Cardiovascular, Obesity, Reproductive

CEU Day 2 Topics - Diabetes and Adrenal

CEU Day 3 Topics - Pituitary and Thyroid

EBR/CEU Disclosures

Day 1 – Thursday, September 6

Day 1 | Day 2 | Day 3

Time Session
7:00 AM Continental Breakfast
7:45–7:55 AM Welcome and Introduction
Janet A. Schlechte, MD
7:55–8:25 AM

Treatment Goals in Osteoporosis: Is No Fracture the Only Marker of Success
Carolyn Becker, MD

8:25–8:55 AM Update on the Management of Renal Bone Disease
Robert A. Wermers, MD
8:55–9:25 AM Osteoporosis: Answers to Patients’ Questions
Ann E. Kearns, MD, PhD
9:25–9:55 AM Hypophosphatemic Disorders and their Management
Suzanne M. Jan de Beur, MD
9:55–10:10 AM Q&A/Panel Discussion
10:10–10:25 AM Coffee Break / Exhibits
10:25–10:55 AM Management of the Patient Before and After Bariatric Surgery
Christopher D. Still, DO
10:55–11:25 AM Pharmacotherapy for Obesity
Marc-Andre Cornier, MD
11:25–11:55 AM Using New and Emerging Therapies in Managing Hypercholesterolemia 
Ira J. Goldberg, MD
11:55 AM–12:10 PM Q&A/Panel Discussion
12:10–1:35 PM Lunch/Exhibits
Optional Conference Events
12:15–1:15 PM Focus Group: Rising Insulin Costs: How You Can Make a Difference
12:20–1:35 PM Improving Obesity Care – A Practical Guide to Engaging and Treating Patients
Chair: Marc-Andre Cornier, MD
The program seeks to close knowledge and practice gaps among clinicians treating patients with obesity. Through incorporating the Provider Competencies for the Prevention and Management of Obesity, the proposed program will focus on the latest information on the current treatment options for obesity and how to start those conversations with patients. 1.25 CME credits (No registration required)
1:40–2:25PM Meet-the-Professor Sessions
2:25–2:40PM  Break/Exhibits
2:40–3:10 PM Menopausal Hormone Therapy and Alternatives
Margaret E. Wierman, MD
3:10–3:40 PM Case-Based Debate of Whether to Start Testosterone Therapy and How to Monitor
Debaters: Moderator: Margaret E. Wierman, MD
3:40–4:00 PM Q&A/Panel Discussion
4:00–4:15 PM Coffee Break/Exhibits
4:15–4:45PM Hyperandrogenic Anovulation: PCOS and Tumors
Margaret E. Wierman, MD
4:45–5:15PM Obesity-Related Low Testosterone
Shehzad Basaria, MD, MBBS
5:15–5:30PM Q&A/Panel Discussion
5:30–5:35PM Break
5:35–6:20PM Meet-the-Professor Sessions
(Sessions Repeat from Earlier)
6:20PM Adjourn
6:30 PM–8:30 PM A GLP-1 RA treatment option from Eli Lilly and Company (Non-CME Program)

 

Day 2 – Friday, September 7

Day 1 | Day 2 | Day 3

Time Session
7:00 AM Continental Breakfast
7:45–7:55 AM Welcome and Introduction
Janet A. Schlechte, MD
7:55–8:25 AM Diabetes and Heart Failure
Matthew A. Cavender, MD, MPH
8:25–8:55 AM What’s New in Continuous Glucose Monitoring?
Anders Carlson, MD
8:55–9:40 AM Renal Outcomes and New Diabetes Medications
Mark E. Molitch, MD
9:40–9:55 AM Q&A/Panel Discussion
9:55–10:10 AM Coffee Break / Exhibits
10:10–10:40 AM Diabete$: Patient$, Doctor$, Insurer$, Manufacturer$, and $ociety
Alvin C. Powers, MD
10:40–11:10 AM What Next After Basal Insulin
Carol Wysham, MD
11:10–11:40 AM Pros and Cons with Non-Insulin Therapies in Gestational Diabetes
Linda Barbour, MD, MSPH
11:40–11:55 AM Q&A/Panel Discussion
11:55 AM–1:10 PM Lunch/Exhibits
Optional Conference Event
12:00–1:00 PM Focus Group: Rising Insulin Costs: How You Can Make a Difference
12:05–1:00 PM Special Presentation
Pens, Pumps and Beyond: A Roundtable Discussion on Advances in Diabetes Technology
1:10–1:55 PM Meet-the-Professor Sessions
1:55–2:05 PM Break/Exhibits
2:05–2:35 PM Congenital Adrenal Hyperplasia: Diagnosis and Treatment
Richard Auchus, MD, PhD
2:35–3:05 PM Adrenal Fatigue and Failure: Fantasy and Facts
James Findling, MD
3:05–3:35 PM Adrenal Cases with Faculty Panel
3:35–3:55 PM  Q&A/Panel Discussion
3:55–4:15 PM Coffee Break / Exhibits
4:15–5:00 PM Meet-the-Professor Sessions
(Sessions Repeat from Earlier)
5:00 PM Adjourn
5:15 PM–7:30 PM Targeting the Brain to Address Insulin Resistance: A Unique Approach in Type 2 Diabetes (Non-CME Program)

 

Day 3 – Saturday, September 8

Day 1 | Day 2 | Day 3

Time Session
7:00 AM Continental Breakfast
Optional Conference Event
7:00–7:40 AM Ancillary Symposium: Quality Payment Program Year 2: Positioning Your Practice for Success (No registration required)
7:45–7:55 AM Welcome and Introduction
Janet A. Schlechte, MD
7:55–8:25 AM Medical Treatment of Acromegaly: A Stepwise Approach
Shlomo Melmed, MD
8:25–8:55 AM Treatment of Cushing Disease when Surgery Fails: Individualized Case-Based Approach
James Findling, MD
8:55–9:25 AM Treatment with Anti-PD-1/PD-L1 and Anti-CTLA-4 Drugs: Endocrine Side Effects
Maria Fleseriu, MD
9:25–9:40 AM Q&A/Panel Discussion
9:40–9:55 AM Coffee Break
9:55–10:40 AM Meet-the-Professor Sessions
10:40–10:50 AM Break
10:50–11:20 AM  Papillary Thyroid Microcarcinomas
Megan R. Haymart, MD
11:20–11:50 AM Subclinical Thyroid Disorders
Kristien Boelaert, MD, PhD
11:50 AM–12:05 PM Q&A/Panel Discussion
12:05–1:20 PM Lunch
Optional Conference Event
12:15–1:15 PM Growth Hormone Deficiency: Diagnosis Challenges and Treatment Considerations
Chair: Shlomo Melmed, MD
This program seeks to close knowledge and practice gaps among clinicians treating patients with growth hormone deficiency (GHD). In this program, Shlomo Melmed, MD and Craig Alter, MD will provide the latest information on ways to improve diagnosis and patient outcomes, approaches to selecting and optimizing growth hormone therapy, and growth hormone therapy transition controversies and strategies. 1.00 CME credits (No registration required)
1:20–2:05 PM Meet-the-Professor Sessions
(Sessions Repeat from Earlier)
2:05–2:10 PM Break
2:10–2:40 PM Overview of Thyroid Nodules
Susan J. Mandel, MD, MPH
2:40–3:25 PM

Challenging Thyroid Cases with Faculty
Kristien Boelaert, MD, PhD
Megan R. Haymart, MD
Susan J. Mandel, MD, MPH

3:25–3:30 PM Closing
Janet A. Schlechte, MD

 
Back to Top